Role of BAZ2A in Cervical Cancer and Its Effect on Tumor Cell Metabolism

Jiarui Xue , Fenglin Dong , Yiwei Liu , Shuqing Wang , Fen Hu , Bin Zhang , Guijie Qi , Zhihao Shen , Rui Guo , Panyan Du , Ying Zhang , Mingjia Zhao , Liyuan Han , Linfeng Zhou , Jinghua Zhang , Yan Liu

Advances in World Medical Research ›› 2025, Vol. 1 ›› Issue (1) : 3 -17.

PDF (1246KB)
Advances in World Medical Research ›› 2025, Vol. 1 ›› Issue (1) :3 -17. DOI: 10.71204/j7y2f615
research-article
Role of BAZ2A in Cervical Cancer and Its Effect on Tumor Cell Metabolism
Author information +
History +
PDF (1246KB)

Abstract

This study aims to investigate the role of BAZ2A in cervical cancer and its relationship with cancer development and glycolipid metabolism. BAZ2A knockdown experiments were performed in HeLa cells to study its effects on cell proliferation, invasion, cloning and migration; transcriptome and metabolome sequencing were also performed, and differentially expressed genes and metabolites were analyzed by GO and KEGG enrichment, etc. BAZ2A is highly expressed in cervical cancer, and the knockdown of BAZ2A inhibits the related malignant behaviors in HeLa cells. Transcriptome analysis identified a large number of differentially - expressed genes and related pathways, while metabolome analysis identified a variety of different metabolites and related pathways. The joint analysis revealed that key genes and metabolites are involved in the BAZ2A regulatory network, affecting the related signaling pathways. Moreover, BAZ2A plays an important role in cervical cancer development and is closely related to glycolipid metabolism. In conclusion, BAZ2A affects cervical cancer development via cell proliferation, cloning, migration, invasion, and energy metabolism.

Keywords

BAZ2A / Cervical Cancer / Transcriptome / Metabolome / Enrichment Analysis

Cite this article

Download citation ▾
Jiarui Xue, Fenglin Dong, Yiwei Liu, Shuqing Wang, Fen Hu, Bin Zhang, Guijie Qi, Zhihao Shen, Rui Guo, Panyan Du, Ying Zhang, Mingjia Zhao, Liyuan Han, Linfeng Zhou, Jinghua Zhang, Yan Liu. Role of BAZ2A in Cervical Cancer and Its Effect on Tumor Cell Metabolism. Advances in World Medical Research, 2025, 1 (1) : 3-17 DOI:10.71204/j7y2f615

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Aktary, Z., Alaee, M., & Pasdar, M. (2017). Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis. Oncotarget, 8(19), 32270-32291.

[2]

Anosova, I., Melnik, S., Tripsianes, K., Kateb, F., Grummt, I., & Sattler, M. (2015). A novel RNA binding surface of the TAM domain of TIP5/BAZ2A mediates epigenetic regulation of rRNA genes. Nucleic Acids Research, 43(10), 5208-5220.

[3]

Bevill, S. M., Olivares-Quintero, J. F., Sciaky, N., Golitz, B. T., Singh, D., Beltran, A. S., et al. (2019). GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer. Molecular Cancer Research, 17(7), 1503-1518.

[4]

Bortoluzzi, A., Amato, A., Lucas, X., Blank, M., & Ciulli, A. (2017). Structural basis of molecular recognition of helical histone H3 tail by PHD finger domains. The Biochemical Journal, 474(10), 1633-1651.

[5]

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424.

[6]

Dalle Vedove, A., Cazzanelli, G., Batiste, L., Marchand, J. R., Spiliotopoulos, D., Corsi, J., et al. (2022). Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing. ACS Medicinal Chemistry Letters, 13(9), 1434-1443.

[7]

GLi, C., Wu, W., Ding, H., Li, Q., & Xie, K. (2018). The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma. Molecular Medicine Reports, 17(6), 7645-7651.

[8]

Grier, D. G., Thompson, A., Kwasniewska, A., McGonigle, G. J., Halliday, H. L., & Lappin, T. R. (2005). The pathophysiology of HOX genes and their role in cancer. The Journal of Pathology, 205(2), 154-171.

[9]

Gu, L., Frommel, S. C., Oakes, C. C., Simon, R., Grupp, K., Gerig, C. Y., et al. (2015). BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nature Genetics, 47(1), 22-30.

[10]

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.

[11]

Jiao, L., Liu, Y., Yu, X. Y., Pan, X., Zhang, Y., Tu, J., et al. (2023). Ribosome biogenesis in disease: new players and therapeutic targets. Signal Transduction and Targeted Therapy, 8(1), 15.

[12]

Johnson, C. A., James, D., Marzan, A., & Armaos, M. (2019). Cervical Cancer: An Overview of Pathophysiology and Management. Seminars in Oncology Nursing, 35(2), 166-174.

[13]

Katanaev, V. L., Kryuchkov, M., Averkov, V., Savitsky, M., Nikolaeva, K., Klimova, N., et al. (2020). HumanaFly: high-throughput transgenesis and expression of breast cancer transcripts in Drosophila eye discovers the RPS12-Wingless signaling axis. Scientific Reports, 10(1), 21013.

[14]

Li, H., Fang, H., Chang, L., Qiu, S., Ren, X., Cao, L., et al. (2021). TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers. Frontiers in Immunology, 12, 764749.

[15]

Liu, J., Ren, L., Li, S., Li, W., Zheng, X., Yang, Y., et al. (2021). The biology, function, and applications of exosomes in cancer. Acta Pharmaceutica Sinica. B, 11(9), 2783-2797.

[16]

Liu, Y., Wang, J., Guo, J., Zhang, Q., Wang, S., Hu, F., et al. (2024). *Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer*. Scientific Reports, 14(1), 5228.

[17]

Liu, Y., Wang, S. Q., Long, Y. H., Chen, S., Li, Y. F., & Zhang, J. H. (2016). KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway. Oncotarget, 7(33), 53153-53164.

[18]

Liu, Y., Zhang, Y. Y., Wang, S. Q., Li, M., Long, Y. H., Li, Y. F., et al. (2020). WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. Oncogene, 39(27), 5056-5067.

[19]

Masters, J. R. (2002). HeLa cells 50 years on: the good, the bad and the ugly. Nature Reviews. Cancer, 2(4), 315-319.

[20]

Neoh, G. K. S., Tan, X., Chen, S., Roura, E., Dong, X., & Gilbert, R. G. (2024). Glycogen metabolism and structure: A review. Carbohydrate Polymers, 346, 122631.

[21]

Pecoraro, A., Pagano, M., Russo, G., & Russo, A. (2021). Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins. International Journal of Molecular Sciences, 22(11), 5496.

[22]

Pietrzak, K., Kuzyakiv, R., Simon, R., Bolis, M., Bär, D., Aprigliano, R., et al. (2020). TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss. Proceedings of the National Academy of Sciences of the United States of America, 117(7), 3637-3647.

[23]

Putarjunan, A., & Torii, K. U. (2016). Stomagenesis versus myogenesis: Parallels in intrinsic and extrinsic regulation of transcription factor mediated specialized cell-type differentiation in plants and animals. Development, Growth & Differentiation, 58(4), 341-354.

[24]

Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12-49.

[25]

Stanley, P. (2011). Golgi glycosylation. Cold Spring Harbor Perspectives in Biology, 3(4), a005199.

[26]

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.

[27]

Tallant, C., Valentini, E., Fedorov, O., Overvoorde, L., Ferguson, F. M., Filippakopoulos, P., et al. (2015). Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC. Structure, 23(1), 80-92.

[28]

Xu, H. H., Yan, W. H., & Lin, A. (2020). The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis. Frontiers in Immunology, 11, 1349.

[29]

Zhang, X., Xia, F., Zhang, X., Blumenthal, R. M., & Cheng, X. (2024). C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies. Journal of Molecular Biology, 436(7), 168343.

[30]

Zou, Z., Tao, T., Li, H., & Zhu, X. (2020). mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell & Bioscience, 10, 31.

PDF (1246KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉